AFFITECH A/S: Financial statements 2020
CVR: 14538372
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
AFFITECH A/S (CVR 14538372) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK 124,803,222 compared with DKK 171,478 the year before. Equity in the 2020 report amounted to DKK 128,565,936. The solvency ratio was 87.4%.
- Profit/Loss
- DKK 124,803,222
- Equity
- DKK 128,565,936
- Total Assets
- DKK 147,178,498
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | 124.8M | 128.6M | - |
| 2019 | - | - | 171K | 3.8M | - |
| 2018 | - | - | 12.6M | 3.6M | - |
| 2017 | - | - | 24M | -9.1M | - |
| 2016 | - | - | -2M | -33.1M | - |
Official annual report
How creditworthy is AFFITECH A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
AFFITECH A/S has published its annual report for 2019. The net result was DKK 171,478.
About AFFITECH A/S
AFFITECH A/S was a Danish company of the type Aktieselskab based in København N, founded in 1990. The company has been dissolved on 2 January 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named PHARMEXA A/S and M&E BIOTECH A/S. The company has 0 employees (2014). In 2021, the company reported a net result of DKK 20,593,000 compared with DKK 124,803,222 the year before. Equity in the 2021 report amounted to DKK 149,159,000.